Ruth Plummer
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 2%
Papers in
- Oncology 104
- PARP inhibition in cancer therapy 39
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Treatments and Studies 17
- Cancer Treatment and Pharmacology 9
-
- DNA Repair Mechanisms 21
- Melanoma and MAPK Pathways 10
- Histone Deacetylase Inhibitors Research 8
- Co-authors
- Hilary Calvert (22 shared papers)Alan V. Boddy (10 shared papers)Johann S. De Bono (20 shared papers)Yvette Drew (13 shared papers)Timothy Anthony Yap (10 shared papers)Mark Ross Middleton (15 shared papers)Richard H. Wilson (12 shared papers)Nicola J. Curtin (12 shared papers)
- Journals
- Annals of Oncology (39 papers)British Journal of Cancer (21 papers)Clinical Cancer Research (14 papers)European Journal of Cancer (12 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Ruth Plummer
181 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 121
- Oncology 3.1k
- Cancer Research 600
- Molecular Biology 3.0k
- Genetics 365
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Ruth Plummer
This map shows the geographic impact of Ruth Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Plummer more than expected).
Fields of papers citing papers by Ruth Plummer
This network shows the impact of papers produced by Ruth Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Plummer. The network helps show where Ruth Plummer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruth Plummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 346 | |
| 2 | 2008 | 327 | |
| 3 | 2008 | 308 | |
| 4 | 2010 | 308 | |
| 5 | 2007 | 208 | |
| 6 | 2019 | 199 | |
| 7 | 2015 | 166 | |
| 8 | 2013 | 158 | |
| 9 | 2017 | 149 | |
| 10 | 2019 | 145 | |
| 11 | 2011 | 142 | |
| 12 | 2016 | 138 | |
| 13 | 2019 | 137 | |
| 14 | 2002 | 129 | |
| 15 | 2018 | 111 | |
| 16 | 2011 | 111 | |
| 17 | 2016 | 108 | |
| 18 | 2013 | 104 | |
| 19 | 2009 | 103 | |
| 20 | 2016 | 103 |
About Ruth Plummer
Ruth Plummer is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 191 papers that have together received 6.4k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (39 papers), DNA Repair Mechanisms (21 papers), Cancer Immunotherapy and Biomarkers (18 papers), Colorectal Cancer Treatments and Studies (17 papers), Lung Cancer Treatments and Mutations (14 papers), Melanoma and MAPK Pathways (10 papers), Cancer Treatment and Pharmacology (9 papers) and Histone Deacetylase Inhibitors Research (8 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (600 citations), Molecular Biology (3.0k citations), Genetics (365 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Ruth Plummer has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Hilary Calvert, Alan V. Boddy, Johann S. De Bono, Yvette Drew, Timothy Anthony Yap, Mark Ross Middleton, Richard H. Wilson, Nicola J. Curtin, Charles David James and W Wick. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Clinical Cancer Research, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.